Features Archives - Page 8 of 20

Features

KPMG’s R&D 2030 report is out now

Our partner KPMG’s latest report on R&D 2030 sheds light on the expected evolution in the R&D ecosystem. It highlights how the ecosystem is due…

clement15.02.2019

Features

BaseLaunch funds four healthcare ventures

BaseLaunch supports carefully selected ventures in two phases. After a very intense pressure test period, four projects were selected for Phase II of our second…

clement22.01.2019

Features

Applications for 2019 are now open

We are excited to be open for new applications. We are looking for people and projects with breakthrough healthcare innovations mainly in the field of…

clement22.01.2019

Features

Looking for an experienced drug developer to join an emerging biotech

A company we are supporting is currently finalizing a substantial Series A round with leading European investors. To complement the team, they are currently looking…

clement22.01.2019

Features

Can a biotech unicorn break into the record books with a $600M IPO? Stéphane Bancel has a fortune riding on the answer

clement29.11.2018

Features

Roivant raised USD 200 million, now valued at USD 7 billion

The Basel-based pharmaceutical company Roivant Sciences has raised USD 200 million in a funding round. As a result, the company is now valued at an…

clement19.11.2018

Features

KPMG’s R&D 2030 report is out now

BaseLaunch funds four healthcare ventures

Applications for 2019 are now open

Looking for an experienced drug developer to join an emerging biotech

Versant partners gear up for a $700M bonanza of biotech bets, with a special focus all their own

A Harvard Professor Made $400 Million in Moderna’s Biotech IPO

Black Diamond turns down an open stretch of R&D highway, headed to a showdown with oncogenes

Infographic: The Basel Biotech & Pharma Ecosystem

Can a biotech unicorn break into the record books with a $600M IPO? Stéphane Bancel has a fortune riding on the answer

Roivant raised USD 200 million, now valued at USD 7 billion

Useful links

Contact us

Sign up for our newsletter and event invitations

Follow us